Literature DB >> 24333085

The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre.

Leonard Kounegnigan Rerambiah1, Laurence Essola Rerambiah2, Calixte Bengone1, Joel F Djoba Siawaya3.   

Abstract

BACKGROUND: Blood transfusions carry the risk of transmitting blood-borne infections. In contrast to the situation in the developed world, there is a limited number of studies examining this problem in sub-Saharan Africa. In this study we aimed to calculate the risks of acquiring human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infection from units of blood issued by the Gabonese Blood Transfusion Centre between 2009 and 2011.
MATERIALS AND METHODS: All the donations were tested for infectious diseases and the seroconversion incidence rates of HIV, HBV and HCV were calculated. The residual risk of transfusion-associated transmission for each virus was calculated by multiplying the seroconversion rates by the window period expressed in fractions of a year.
RESULTS: The risks of becoming infected with HIV, HCV, and HBV in subjects receiving units of blood from the Gabonese Blood Transfusion Centre were 64.7, 207.94 and 534.53 per million donations, respectively.
CONCLUSIONS: This study, which is the first to quantify the true risks of transfusion-transmitted infections in Gabon, reveals and confirms the need to reinforce preventative and screening strategies to improve transfusion safety in sub-Saharan Africa.

Entities:  

Mesh:

Year:  2013        PMID: 24333085      PMCID: PMC4111813          DOI: 10.2450/2013.0144-13

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  26 in total

1.  [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].

Authors:  J Pillonel; S Laperche
Journal:  Transfus Clin Biol       Date:  2004-04       Impact factor: 1.406

2.  Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review.

Authors:  R Cable; N Lelie; A Bird
Journal:  Vox Sang       Date:  2012-08-28       Impact factor: 2.144

3.  Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.

Authors:  Laila Al Shaer; Mahera AbdulRahman; Thomas J John; Ali AlHashimi
Journal:  Transfusion       Date:  2012-06-13       Impact factor: 3.157

Review 4.  The risk of transfusion-transmitted infections in sub-Saharan Africa.

Authors:  Sudha Jayaraman; Zaid Chalabi; Pablo Perel; Carla Guerriero; Ian Roberts
Journal:  Transfusion       Date:  2009-10-15       Impact factor: 3.157

5.  The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations.

Authors:  B R Jackson; M P Busch; S L Stramer; J P AuBuchon
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

6.  HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors.

Authors:  A Diarra; B Kouriba; M Baby; E Murphy; J-J Lefrere
Journal:  Transfus Clin Biol       Date:  2009-11-05       Impact factor: 1.406

Review 7.  Transfusion-transmissible infections.

Authors:  H Vrielink; H W Reesink
Journal:  Curr Opin Hematol       Date:  1998-11       Impact factor: 3.284

8.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Authors:  G B Schreiber; M P Busch; S H Kleinman; J J Korelitz
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

9.  Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.

Authors:  Moon Jung Kim; Quehn Park; Hyuk Ki Min; Hyun Ok Kim
Journal:  BMC Infect Dis       Date:  2012-07-20       Impact factor: 3.090

10.  High Rates of Hepatitis B and C and HIV Infections among Blood Donors in Cameroon: A Proposed Blood Screening Algorithm for Blood Donors in Resource-Limited Settings.

Authors:  Florent Fouelifack Ymele; Basile Keugoung; Jeanne Hortense Fouedjio; Nadege Kouam; Sandrine Mendibi; Jacqueline Dongtsa Mabou
Journal:  J Blood Transfus       Date:  2012-09-19
View more
  12 in total

1.  EFFICACY OF EXTENDED ORAL TRANEXAMIC ACID ON BLOOD LOSS IN PRIMARY TOTAL KNEE ARTHROPLASTY.

Authors:  Varah Yuenyongviwat; Kantapon Dissaneewate; Khanin Iamthanaporn; Pakjai Tuntarattanapong; Theerawit Hongnaparak
Journal:  Acta Ortop Bras       Date:  2022-07-06       Impact factor: 0.683

2.  Assessment of rapid diagnostic tests and fourth-generation Enzyme-Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first-time blood donors in Libreville (Gabon).

Authors:  Jean Marie Eko Mba; Cyrille Bisseye; Landry Erik Mombo; Jophrette Mireille Ntsame Ndong; Schella Carlaye Mbina Ekayeng; Calixte Bengone; Bertrand M'batchi; Bolni Marius Nagalo
Journal:  J Clin Lab Anal       Date:  2018-11-28       Impact factor: 2.352

3.  Application of Perioperative Transfusion Trigger Score in Patients Undergoing Surgical Treatment of Malignant Tumor.

Authors:  Fan Zhang; Ze-Bing Zheng; Zhao-Qiong Zhu; De-Xing Liu; Jin Liu
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-12       Impact factor: 0.900

4.  Blood transfusion, serum ferritin, and iron in hemodialysis patients in Africa.

Authors:  Leonard Kouegnigan Rerambiah; Laurence Essola Rerambiah; Armel Mbourou Etomba; Rose Marlène Mouguiama; Phanie Brunelle Issanga; Axel Sydney Biyoghe; Batchelili Batchilili; Sylvestre Akone Assembe; Joel Fleury Djoba Siawaya
Journal:  J Blood Transfus       Date:  2015-01-11

5.  Hepatitis E Virus Prevalence among Blood Donors, Ouagadougou, Burkina Faso.

Authors:  Kuan A Traoré; Jean Bienvenue Ouoba; Hortense Rouamba; Yacouba K Nébié; Honorine Dahourou; Frédéric Rossetto; Alfred S Traoré; Nicolas Barro; Pierre Roques
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

6.  Prevalent hepatitis B surface antigen among first-time blood donors in Gabon.

Authors:  Jean Marie Eko Mba; Cyrille Bisseye; Jophrette Mireille Ntsame Ndong; Landry Erik Mombo; Calixte Bengone; Guy Mouelet Migolet; Bertrand M'batchi; Heidi E Kosiorek; Richard J Butterfield; Lewis R Roberts; Mitesh J Borad; Bolni Marius Nagalo
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

Review 7.  Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso.

Authors:  Arzouma Paul Yooda; Salam Sawadogo; Serge Théophile Soubeiga; Dorcas Obiri-Yeboah; Koumpingnin Nebie; Abdoul Karim Ouattara; Birama Diarra; Abibou Simpore; Yetema Dieudonné Yonli; Abdoul-Guaniyi Sawadogo; Bia Emile Drabo; Seimbou Zalla; Anita Pierrette Siritié; Rodrigue Sosthène Nana; Honorine Dahourou; Jacques Simpore
Journal:  J Blood Med       Date:  2019-02-01

8.  Trends of blood-borne infectious diseases in a rural blood donation center of southeast Gabon (Koula-Moutou).

Authors:  Cyrille Bisseye; Landry-Erik Mombo; Stéphane Meyet Me Bie; Apollinaire Edou; Jean Marie Eko-Mba; Jean-Charles Etho-Mengue; Kévin Mbacky; Arnaud Mongo-Delis; Bertrand M'batchi; Bolni Marius Nagalo
Journal:  Pan Afr Med J       Date:  2018-10-03

9.  Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study.

Authors:  Belete Biadgo; Elias Shiferaw; Berhanu Woldu; Kefyalew Addis Alene; Mulugeta Melku
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

10.  Seroprevalence and Knowledge of Hepatitis B Virus Infection Among LaboratoryWorkers at Kilimanjaro Christian Medical Centre in Moshi, Tanzania.

Authors:  Richard E Machange; Dominic Mosha; Jeremia J Pyuza; Balthazar B Nyombi; Elichilia R Shao
Journal:  East Afr Health Res J       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.